BriaCell Therapeutics (BCTXW) Short Interest Ratio & Short Volume → How this is some devastating news (From WealthPress) (Ad) Free BCTXW Stock Alerts $0.59 +0.04 (+7.26%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media BriaCell Therapeutics Short Interest DataCurrent Short Volume2,400 sharesPrevious Short Volume600 sharesChange Vs. Previous Month+300.00%Dollar Volume Sold Short$2,184.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Today's Trading Volume27,771 sharesAverage Trading Volume29,332 sharesToday's Volume Vs. Average95% Short Selling BriaCell Therapeutics ? Sign up to receive the latest short interest report for BriaCell Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBCTXW Short Interest Over TimeBCTXW Days to Cover Over TimeBCTXW Percentage of Float Shorted Over Time Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. BriaCell Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,400 shares $2,184.00 +300.0%N/A0.1 $0.91 4/15/2024600 shares $672.00 No ChangeN/A0 $1.12 3/31/2024600 shares $816.00 -81.3%N/A0 $1.36 3/15/20243,200 shares $4,829.76 -22.0%N/A0.3 $1.51 2/29/20244,100 shares $7,585.00 +70.8%N/A0.4 $1.85 2/15/20242,400 shares $3,575.76 +140.0%N/A0.2 $1.49 Get the Latest News and Ratings for BCTXW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,000 shares $1,780.00 -47.4%N/A0.1 $1.78 1/15/20241,900 shares $3,800.00 -50.0%N/A0.2 $2.00 12/31/20233,800 shares $9,500.00 +100.0%N/A0.3 $2.50 12/15/20231,900 shares $3,325.00 +375.0%N/A0.2 $1.75 11/30/2023400 shares $900.00 -60.0%N/A0 $2.25 11/15/20231,000 shares $1,630.00 +42.9%N/A0.1 $1.63 10/31/2023700 shares $707.00 -87.7%N/A0 $1.01 10/15/20235,700 shares $8,379.00 +185.0%N/A0.3 $1.47 9/30/20232,000 shares $4,940.00 +11.1%N/A0.1 $2.47 9/15/20231,800 shares $4,374.00 -76.3%N/A0.1 $2.43 8/31/20237,600 shares $19,760.00 -20.0%N/A0.4 $2.60 8/15/20239,500 shares $24,320.00 +4,650.0%N/A0.5 $2.56 7/31/2023200 shares $500.00 -88.2%N/A0 $2.50 7/15/20231,700 shares $4,250.00 No ChangeN/A0.1 $2.50 6/30/20231,700 shares $4,250.00 +54.6%N/A0.1 $2.50 6/15/20231,100 shares $2,959.00 +450.0%N/A0.1 $2.69 5/31/2023200 shares $490.00 -87.5%N/A0 $2.45 5/15/20231,600 shares $4,320.00 -65.2%N/A0.2 $2.70 4/30/20234,600 shares $13,869.00 -13.2%N/A0.3 $3.02 4/15/20235,300 shares $15,635.00 +12.8%N/A0.3 $2.95 3/31/20234,700 shares $13,912.00 -25.4%N/A0.3 $2.96 3/15/20236,300 shares $18,711.00 -13.7%N/A0.4 $2.97 2/28/20237,300 shares $22,338.00 +55.3%N/A0.4 $3.06 2/15/20234,700 shares $15,792.00 -9.6%N/A0.3 $3.36 1/31/20235,200 shares $15,548.00 +26.8%N/A0.4 $2.99 1/15/20234,100 shares $10,454.59 +310.0%N/A0.3 $2.55 12/30/20221,000 shares $2,059.90 -58.3%N/A0.1 $2.06 12/15/20222,400 shares $5,160.00 +166.7%N/A0.3 $2.15 11/30/2022900 shares $1,800.00 +200.0%N/A0.1 $2.00 11/15/2022300 shares $642.00 -25.0%N/A0 $2.14 10/31/2022400 shares $1,108.00 -69.2%N/A0 $2.77 10/15/20221,300 shares $3,965.00 -18.8%N/A0.1 $3.05 9/30/20221,600 shares $4,592.00 No ChangeN/A0.1 $2.87 9/15/20221,600 shares $6,079.84 -50.0%N/A0.1 $3.80Free report reveals “two-baggers” for 2024 (Ad)We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.Download your free report today! BCTXW Short Interest - Frequently Asked Questions What is BriaCell Therapeutics' current short interest? Short interest is the volume of BriaCell Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,400 shares of BCTXW short. Learn More on BriaCell Therapeutics' current short interest. Is BriaCell Therapeutics' short interest increasing or decreasing? BriaCell Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,400 shares, an increase of 300.0% from the previous total of 600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short BriaCell Therapeutics stock? Short selling BCTXW is an investing strategy that aims to generate trading profit from BriaCell Therapeutics as its price is falling. BCTXW shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BriaCell Therapeutics? A short squeeze for BriaCell Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTXW, which in turn drives the price of the stock up even further. How often is BriaCell Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTXW, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ATNFW Short Interest DRTSW Short Interest APLMW Short Interest ARTLW Short Interest CDIOW Short Interest CTCXW Short Interest SAVAW Short Interest CELUW Short Interest CLNNW Short Interest CDTTW Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCTXW) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press